Scientific publications
Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH-SETH
Nov 30, 2021
| Magazine: Clinical & Translational Oncology
J R Gonzalez-Porras 1 , J Mateo 2 , V Gonzalez-Calle 3 , P Marco 4 , V Garcia-Gutierrez 5 , J C Reverter 6 , R Lecumberri 7
Abstract
Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement.
However, prospective studies with large enough cohorts are scarce, limiting the development of evidence-based thromboprophylaxis guidelines. The present position paper is addressed to all hematologists treating patients affected by hematologic neoplasms with the aim to provide clinicians with a useful tool for the prevention of VTE.
CITATION Clin Transl Oncol. 2022 May;24(5):770-783.
doi: 10.1007/s12094-021-02735-1. Epub 2021 Nov 30.
Our authors
